MARKER THERAPEUTICS, INC. Notes Payable, Current
MARKER THERAPEUTICS, INC. (MRKR) had Notes Payable, Current of $5.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2018-11-13
- 2018-09-30: Notes Payable, Current $5.00K.
- 2018-06-30: Notes Payable, Current $5.00K.
- 2018-03-31: Notes Payable, Current $5.00K.
- 2017-12-31: Notes Payable, Current $5.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2018-09-30 | $5.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $5.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $5.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $5.00K 10-Q · filed 2018-11-13 |
| 2017-09-30 | $5.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $5.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $5.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $5.00K 10-K · filed 2018-03-23 |
| 2016-09-30 | $5.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $5.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $5.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $30.00K 10-K · filed 2017-03-14 |
| 2014-12-31 | $52.94K 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |